GUNA-TONSILS

Manufacturer: Guna spa
Effective date: 2018-12-21
Label type: HUMAN OTC DRUG LABEL
Version: 4
Source: full-release
Hydrated at: 2026-06-01 02:10:42

Label at a glance#

ProductGUNA-TONSILS

Active ingredientANGELICA SINENSIS ROOT, SUS SCROFA BLOOD, LENOGRASTIM, INTERLEUKIN-11, INTERLEUKIN-3, BINETRAKIN, SHIITAKE MUSHROOM, REISHI, SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE, MELATONIN, SUS SCROFA SPLEEN

Label structure10 sections

Indications and uses

Temporary relief of symptoms due to Tonsillitis such as: Sore throat Loss of voice Swollen lymph nodes

Dosage and administration

Take 15 minutes before meals Adults and children 12 years and older 5 pellets 3 times per day Children between 12 years and 6 years of age 3 pellets 3 times per day Children under 6 years 1 pellet 3 times per day to be dissolved into a little water

Contacts and useful links#

PhoneLabel contact(484) 223-3500

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS/PURPOSE

OTC - ACTIVE INGREDIENT SECTION

ANGELICA SINENSIS, RADIX    3X    DETOXIFICATION
BLOOD                                    4C, 7C    PROMOTES RECOVERY
GCSF                                      4C    STRENGTHENS IMMUNE RESPONSE
INTERLEUKIN 11                    5C    ANTI-INFLAMMATORY
INTERLEUKIN 3                        5C    STRENGTHENS IMMUNE RESPONSE
INTERLEUKIN 4                        4C    IMMUNE SUPPORT
JAPANESE FOREST MUSHROOM    8X    STRENGTHENS IMMUNE RESPONSE
LING CHI MUSHROOM        8X    ANTIOXIDANT
LYMPHATIC GLAND            4C    STRENGTHENS RESISTANCE TO INFECTION
MELATONIN            4C, 7C    ANTIOXIDANT
SPLEEN                4C    STRENGTHENS RESISTANCE TO INFECTION

USES

OTC - PURPOSE SECTION

Temporary relief of symptoms due to Tonsillitis such as:

Sore throat
Loss of voice
Swollen lymph nodes

WARNINGS

WARNINGS SECTION

Stop use and ask doctor if symptoms persist more than 5 days or worsen.
If pregnant or breast-feeding ask a health professional before use.
Keep out of reach of children.

PREGNANCY

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding ask a health professional before use.

WARNINGS

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medicines out of reach of children

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Take 15 minutes before meals

Adults and children 12 years and older 5 pellets 3 times per day

Children between 12 years and 6 years of age 3 pellets 3 times per day

Children under 6 years 1 pellet 3 times per day to be dissolved into a little water

QUESTIONS

OTC - QUESTIONS SECTION

Questions?: info@gunainc.com
tel. (484) 223-3500

INDICATIONS & USAGE SECTION

Turn tube upside down and rotate cap to release pellets into cap.
Unscrew cap and without touching pellets tip them into the mouth under the tongue.
Allow to dissolve
Take 15 minutes before meals.

INACTIVE INGREDIENT SECTION

Inactive ingredient: Sucrose.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

5USTON-Guna-Tonsils-rev02-110718

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
17089-235-20	GUNA-TONSILS	4 g in 1 TUBE	PELLET	4		4
17089-235-20	GUNA-TONSILS	2 in 1 BOX	PELLET	2		4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17089-235	GUNA-TONSILS (ANGELICA SINENSIS ROOT - BINETRAKIN - INTERLEUKIN-3 - LENOGRASTIM - MELATONIN - REISHI - SHIITAKE MUSHROOM - SUS SCROFA BLOOD - SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE - SUS SCROFA SPLEEN - INTERLEUKIN-11 -) PELLET [GUNA SPA]	4	Current NDC, Legacy NDC, 2 package rows	20190104_b7d0a24f-c702-4b4a-8494-a4cbbb020257.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ANGELICA SINENSIS ROOT	ACTIVE INGREDIENT	B66F4574UG	3
BINETRAKIN	ACTIVE INGREDIENT	751635Z921	3
INTERLEUKIN-11	ACTIVE INGREDIENT	O14Q7A13PT	3
INTERLEUKIN-3	ACTIVE INGREDIENT	A802907MI4	3
LENOGRASTIM	ACTIVE INGREDIENT	6WS4C399GB	3
MELATONIN	ACTIVE INGREDIENT	JL5DK93RCL	3
REISHI	ACTIVE INGREDIENT	TKD8LH0X2Z	3
SHIITAKE MUSHROOM	ACTIVE INGREDIENT	1A64QN2D2F	3
SUS SCROFA BLOOD	ACTIVE INGREDIENT	994R458ECK	3
SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE	ACTIVE INGREDIENT	308LM01C72	3
SUS SCROFA SPLEEN	ACTIVE INGREDIENT	92AMN5J79Y	3
ANGELICA SINENSIS ROOT	ACTIVE MOIETY	B66F4574UG	3
BINETRAKIN	ACTIVE MOIETY	751635Z921	3
INTERLEUKIN-11	ACTIVE MOIETY	O14Q7A13PT	3
INTERLEUKIN-3	ACTIVE MOIETY	A802907MI4	3
LENOGRASTIM	ACTIVE MOIETY	6WS4C399GB	3
MELATONIN	ACTIVE MOIETY	JL5DK93RCL	3
REISHI	ACTIVE MOIETY	TKD8LH0X2Z	3
SHIITAKE MUSHROOM	ACTIVE MOIETY	1A64QN2D2F	3
SUS SCROFA BLOOD	ACTIVE MOIETY	994R458ECK	3
SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE	ACTIVE MOIETY	308LM01C72	3
SUS SCROFA SPLEEN	ACTIVE MOIETY	92AMN5J79Y	3
SUCROSE	INACTIVE INGREDIENT	C151H8M554	3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

GUNA-TONSILS
angelica sinensis root - binetrakin - interleukin-3 - lenograstim - melatonin - reishi - shiitake mushroom - sus scrofa blood - sus scrofa small intestine mucosa lymph follicle - sus scrofa spleen - interleukin-11 -
SUCROSE
ANGELICA SINENSIS ROOT
SUS SCROFA BLOOD
LENOGRASTIM
INTERLEUKIN-11
INTERLEUKIN-3
BINETRAKIN
SHIITAKE MUSHROOM
REISHI
SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE
MELATONIN
SUS SCROFA SPLEEN

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
17089-235	17089-235-20

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SUCROSE	C151H8M554	IACT
ANGELICA SINENSIS ROOT	B66F4574UG	ACTIB
SUS SCROFA BLOOD	994R458ECK	ACTIB
LENOGRASTIM	6WS4C399GB	ACTIB
INTERLEUKIN-11	O14Q7A13PT	ACTIB
INTERLEUKIN-3	A802907MI4	ACTIB
BINETRAKIN	751635Z921	ACTIB
SHIITAKE MUSHROOM	1A64QN2D2F	ACTIB
REISHI	TKD8LH0X2Z	ACTIB
SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE	308LM01C72	ACTIB
MELATONIN	JL5DK93RCL	ACTIB
SUS SCROFA SPLEEN	92AMN5J79Y	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 62 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii+route 62 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
GUNA-TONSILS	ANGELICA SINENSIS ROOT - BINETRAKIN - INTERLEUKIN-3 - LENOGRASTIM - MELATONIN - REISHI - SHIITAKE MUSHROOM - SUS SCROFA BLOOD - SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE - SUS SCROFA SPLEEN - INTERLEUKIN-11 -	Guna spa	b7d0a24f-c702-4b4a-8494-a4cbbb020257	2018-12-21	Warnings	Exact identifier ndc (package): 17089-235-20 ndc (product): 17089-235 ndc11 (package): 17089023520 spl id: 7e8f9d55-ff7c-cbe7-e053-2a91aa0a382e spl set id: b7d0a24f-c702-4b4a-8494-a4cbbb020257

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.